Despite Criticism Of The FDA Review Process, New Cancer Drugs Reach Patients Sooner In The United States Than In Europe

Allen, J D; Sigal, E. V.; Roberts, S A

doi:10.1377/hlthaff.2011.0231

Record: found
Abstract: not found
Article: not found

Despite Criticism Of The FDA Review Process, New Cancer Drugs Reach Patients Sooner In The United States Than In Europe

Author(s): S. A. Roberts , J. D. Allen , E. V. Sigal

Publication date Created: July 06 2011

Publication date (Print): June 16 2011

Journal: Health Affairs

Publisher: Health Affairs (Project Hope)

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Health Affairs

Abbreviated Title: Health Affairs

Publisher: Health Affairs (Project Hope)

ISSN (Print): 0278-2715

ISSN (Electronic): 1544-5208

Publication date Created: July 06 2011

Publication date (Print): June 16 2011

Volume: 30

Issue: 7

Pages: 1375-1381

Article

DOI: 10.1377/hlthaff.2011.0231

SO-VID: 01a24134-92a0-4803-a060-c906006cf391

History

Data availability:

Despite Criticism Of The FDA Review Process, New Cancer Drugs Reach Patients Sooner In The United States Than In Europe

Read this article at

Related collections

Special feature: Europe and Education

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 2,867

Cited by 20